<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS Biol</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosbiol</journal-id>
<journal-title-group>
<journal-title>PLOS Biology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1544-9173</issn>
<issn pub-type="epub">1545-7885</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pbio.3000047</article-id>
<article-id pub-id-type="publisher-id">PBIOLOGY-D-18-00453</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Short Reports</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Inflammatory diseases</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune system proteins</subject><subj-group><subject>Inflammasomes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune system proteins</subject><subj-group><subject>Inflammasomes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Biochemistry</subject><subj-group><subject>Proteins</subject><subj-group><subject>Immune system proteins</subject><subj-group><subject>Inflammasomes</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Animal studies</subject><subj-group><subject>Experimental organism systems</subject><subj-group><subject>Model organisms</subject><subj-group><subject>Mouse models</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Model organisms</subject><subj-group><subject>Mouse models</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Animal studies</subject><subj-group><subject>Experimental organism systems</subject><subj-group><subject>Animal models</subject><subj-group><subject>Mouse models</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Cell biology</subject><subj-group><subject>Cellular types</subject><subj-group><subject>Animal cells</subject><subj-group><subject>Bone marrow cells</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Immune physiology</subject><subj-group><subject>Spleen</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Immune physiology</subject><subj-group><subject>Spleen</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and analysis methods</subject><subj-group><subject>Spectrum analysis techniques</subject><subj-group><subject>Spectrophotometry</subject><subj-group><subject>Cytophotometry</subject><subj-group><subject>Flow cytometry</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Pathogenesis</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Immune physiology</subject><subj-group><subject>Cytokines</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Immune physiology</subject><subj-group><subject>Cytokines</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune system</subject><subj-group><subject>Innate immune system</subject><subj-group><subject>Cytokines</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Immune system</subject><subj-group><subject>Innate immune system</subject><subj-group><subject>Cytokines</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Developmental biology</subject><subj-group><subject>Molecular development</subject><subj-group><subject>Cytokines</subject></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Gasdermin D mediates the pathogenesis of neonatal-onset multisystem inflammatory disease in mice</article-title>
<alt-title alt-title-type="running-head">GSDMD deficiency prevents the onset of NOMID</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Xiao</surname>
<given-names>Jianqiu</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple">
<name name-style="western">
<surname>Wang</surname>
<given-names>Chun</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-2041-9867</contrib-id>
<name name-style="western">
<surname>Yao</surname>
<given-names>Juo-Chin</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-2760-7155</contrib-id>
<name name-style="western">
<surname>Alippe</surname>
<given-names>Yael</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Xu</surname>
<given-names>Canxin</given-names>
</name>
<role content-type="http://credit.casrai.org/">Methodology</role>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Kress</surname>
<given-names>Dustin</given-names>
</name>
<role content-type="http://credit.casrai.org/">Data curation</role>
<role content-type="http://credit.casrai.org/">Formal analysis</role>
<role content-type="http://credit.casrai.org/">Methodology</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-4076-4315</contrib-id>
<name name-style="western">
<surname>Civitelli</surname>
<given-names>Roberto</given-names>
</name>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Abu-Amer</surname>
<given-names>Yousef</given-names>
</name>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Kanneganti</surname>
<given-names>Thirumala-Devi</given-names>
</name>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff005"><sup>5</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Link</surname>
<given-names>Daniel C.</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Resources</role>
<role content-type="http://credit.casrai.org/">Visualization</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-4660-0952</contrib-id>
<name name-style="western">
<surname>Mbalaviele</surname>
<given-names>Gabriel</given-names>
</name>
<role content-type="http://credit.casrai.org/">Conceptualization</role>
<role content-type="http://credit.casrai.org/">Funding acquisition</role>
<role content-type="http://credit.casrai.org/">Supervision</role>
<role content-type="http://credit.casrai.org/">Writing – original draft</role>
<role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>Division of Bone and Mineral Diseases, Washington University School of Medicine, St. Louis, Missouri, United States of America</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Division of Oncology, Washington University School of Medicine, St. Louis, Missouri, United States of America</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Confluence Discovery Technologies, Inc., St. Louis, Missouri, United States of America</addr-line></aff>
<aff id="aff004"><label>4</label> <addr-line>Department of Orthopedic Surgery, Washington University School of Medicine and Shriners Hospital for Children, St. Louis, Missouri, United States of America</addr-line></aff>
<aff id="aff005"><label>5</label> <addr-line>Department of Immunology, St. Jude Children’s Research Hospital, Memphis, Tennessee, United States of America</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>Bhandoola</surname>
<given-names>Avinash</given-names>
</name>
<role>Academic Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>National Cancer Institute, UNITED STATES</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>I have read the journal's policy and the authors of this manuscript have the following competing interests: GM is a consultant for Aclaris Therapeutics, Inc., and holds stocks of this company. RC receives research support from Amgen, and holds stock of Amgen, Eli- Lilly, and Merck &amp; Co.</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">gmbalaviele@wustl.edu</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>2</day>
<month>11</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<month>11</month>
<year>2018</year>
</pub-date>
<volume>16</volume>
<issue>11</issue>
<elocation-id>e3000047</elocation-id>
<history>
<date date-type="received">
<day>14</day>
<month>8</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>10</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-year>2018</copyright-year>
<copyright-holder>Xiao et al</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pbio.3000047"/>
<abstract>
<p>Mutated NLRP3 assembles a hyperactive inflammasome, which causes excessive secretion of interleukin (IL)-1β and IL-18 and, ultimately, a spectrum of autoinflammatory disorders known as cryopyrinopathies of which neonatal-onset multisystem inflammatory disease (NOMID) is the most severe phenotype. NOMID mice phenocopy several features of the human disease as they develop severe systemic inflammation driven by IL-1β and IL-18 overproduction associated with damage to multiple organs, including spleen, skin, liver, and skeleton. Secretion of IL-1β and IL-18 requires gasdermin D (GSDMD), which—upon activation by the inflammasomes—translocates to the plasma membrane where it forms pores through which these cytokines are released. However, excessive pore formation resulting from sustained activation of GSDMD compromises membrane integrity and ultimately causes a pro-inflammatory form of cell death, termed pyroptosis. In this study, we first established a strong correlation between NLRP3 inflammasome activation and GSDMD processing and pyroptosis in vitro. Next, we used NOMID mice to determine the extent to which GSDMD-driven pyroptosis influences the pathogenesis of this disorder. Remarkably, all NOMID-associated inflammatory symptoms are prevented upon ablation of GSDMD. Thus, GSDMD-dependent actions are required for the pathogenesis of NOMID in mice.</p>
</abstract>
<abstract abstract-type="toc">
<p>Pyroptosis mediated by the pore-forming protein gasdermin D plays a crucial role in the pathogenesis of neonatal-onset multisystem inflammatory disease, a severe genetic autoinflammatory disorder resulting from activating mutations in the NLRP3/cryopyrin gene.</p>
</abstract>
<abstract abstract-type="summary">
<title>Author summary</title>
<p>The NLRP3 inflammasome plays an important role in the maturation of interleukin (IL)-1β and IL-18. Accordingly, <italic>NLRP3</italic> gain-of-function mutations, which cause a spectrum of autoinflammatory disorders known as cryopyrin-associated periodic syndromes (CAPS), are associated with excessive IL-1β and IL-18 production. Although CAPS-associated inflammatory symptoms are treated with IL-1-blocking agents, emerging evidence indicates that some CAPS patients only partially respond to these drugs. Persistent inflammatory responses have also been reported in CAPS mice deficient in IL-1β and IL-18 signaling and may be the consequences of the pro-inflammatory cell death, pyroptosis, which is induced by gasdermin D (GSDMD), the other effector of the inflammasomes. Consistent with this view, we found that damage to multiple organs that manifested in a mouse model of CAPS was prevented by ablation of GSDMD.</p>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000069</institution-id>
<institution>National Institute of Arthritis and Musculoskeletal and Skin Diseases</institution>
</institution-wrap>
</funding-source>
<award-id>AR064755</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-4660-0952</contrib-id>
<name name-style="western">
<surname>Mbalaviele</surname>
<given-names>Gabriel</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award002">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000069</institution-id>
<institution>National Institute of Arthritis and Musculoskeletal and Skin Diseases</institution>
</institution-wrap>
</funding-source>
<award-id>AR068972</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-4660-0952</contrib-id>
<name name-style="western">
<surname>Mbalaviele</surname>
<given-names>Gabriel</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award003">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000069</institution-id>
<institution>National Institute of Arthritis and Musculoskeletal and Skin Diseases</institution>
</institution-wrap>
</funding-source>
<award-id>AR049192</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>Abu-Amer</surname>
<given-names>Yousef</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award004">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000069</institution-id>
<institution>National Institute of Arthritis and Musculoskeletal and Skin Diseases</institution>
</institution-wrap>
</funding-source>
<award-id>AR054326</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>Abu-Amer</surname>
<given-names>Yousef</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award005">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100011781</institution-id>
<institution>Shriners Hospitals for Children</institution>
</institution-wrap>
</funding-source>
<award-id>AR072623</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>Abu-Amer</surname>
<given-names>Yousef</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>This work was supported by NIH/NIAMS AR064755 and AR068972 grants to GM. YA-A is supported by NIH grants AR049192, AR072623, and AR054326 and by a grant from the Shriners Hospital for Children.</funding-statement>
</funding-group>
<counts>
<fig-count count="4"/>
<table-count count="0"/>
<page-count count="13"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>PLOS Publication Stage</meta-name>
<meta-value>vor-update-to-uncorrected-proof</meta-value>
</custom-meta>
<custom-meta>
<meta-name>Publication Update</meta-name>
<meta-value>2018-11-14</meta-value>
</custom-meta>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec001" sec-type="intro">
<title>Introduction</title>
<p>NLRP3, also called cryopyrin, assembles an inflammasome complex upon sensing danger signals triggered by structurally different exogenous and endogenous molecular entities [<xref ref-type="bibr" rid="pbio.3000047.ref001">1</xref>–<xref ref-type="bibr" rid="pbio.3000047.ref003">3</xref>]. Failure to clear the insults or restore homeostasis leads to chronic activation of this inflammasome, a response that underlies various inflammatory and metabolic diseases, including gout, diabetes, and atherosclerosis [<xref ref-type="bibr" rid="pbio.3000047.ref004">4</xref>]. Activating mutations in the <italic>NLRP3</italic> gene also cause constitutive activation of the NLRP3 inflammasome in patients with a spectrum of autoinflammatory disorders known as cryopyrinopathies or cryopyrin-associated periodic syndromes (CAPS), which include neonatal-onset multisystem inflammatory disease (NOMID), Muckle-Wells syndrome (MWS), and familial cold autoinflammatory syndrome (FCAS) [<xref ref-type="bibr" rid="pbio.3000047.ref005">5</xref>, <xref ref-type="bibr" rid="pbio.3000047.ref006">6</xref>]. CAPS are monogenic disorders with some degree of genotype-phenotype correlation, with NOMID exhibiting the most severe manifestations [<xref ref-type="bibr" rid="pbio.3000047.ref005">5</xref>, <xref ref-type="bibr" rid="pbio.3000047.ref006">6</xref>]. Each of the CAPS phenotypes displays multiple symptoms, including systemic inflammation, recurrent or chronic fever, and urticaria-like rash [<xref ref-type="bibr" rid="pbio.3000047.ref005">5</xref>, <xref ref-type="bibr" rid="pbio.3000047.ref006">6</xref>].</p>
<p>Consistent with the NLRP3 inflammasome role in interleukin (IL)-1β and IL-18 maturation, cryopyrinopathies are associated with excessive production of these cytokines. Accordingly, IL-1-blocking drugs are widely used in the management of these disorders. However, it appears that some CAPS patients only partially respond to IL-1 biologics [<xref ref-type="bibr" rid="pbio.3000047.ref007">7</xref>–<xref ref-type="bibr" rid="pbio.3000047.ref009">9</xref>]. In addition, skeletal lesions, the hallmark of NOMID, are refractory to IL-1 blockade [<xref ref-type="bibr" rid="pbio.3000047.ref010">10</xref>–<xref ref-type="bibr" rid="pbio.3000047.ref013">13</xref>]. These clinical observations underscore the complexity of cryopyrinopathies by suggesting that other actions of the inflammasomes beyond maturation of cytokines also contribute to the pathogenesis of these disorders. Indeed, the NLRP3 inflammasome also processes gasdermin D (GSDMD) into GSDMD-N (N-terminal domain) and GSDMD-C (C-terminal domain) [<xref ref-type="bibr" rid="pbio.3000047.ref014">14</xref>–<xref ref-type="bibr" rid="pbio.3000047.ref016">16</xref>]. GSDMD-N translocates to the plasma membrane, where it binds phospholipids and forms pores at the plasma membrane through which IL-1β and IL-18 are secreted by living cells [<xref ref-type="bibr" rid="pbio.3000047.ref017">17</xref>–<xref ref-type="bibr" rid="pbio.3000047.ref019">19</xref>]. Sustained activity of the inflammasomes causes excessive maturation of GSDMD and pore formation; this leads to membrane perforation and, ultimately, pyroptosis [<xref ref-type="bibr" rid="pbio.3000047.ref017">17</xref>, <xref ref-type="bibr" rid="pbio.3000047.ref020">20</xref>–<xref ref-type="bibr" rid="pbio.3000047.ref023">23</xref>]. This form of cell death provokes the uncontrolled release of not only IL-1β and IL-18 but also cytoplasmic contents, resulting in the recruitment of immune cells and propagation of inflammation [<xref ref-type="bibr" rid="pbio.3000047.ref017">17</xref>, <xref ref-type="bibr" rid="pbio.3000047.ref024">24</xref>]. Thus, pyroptosis is not a silent endpoint, but the extent to which this pathologic process influences the pathogenesis of cryopyrinopathies is unknown.</p>
<p>Knockin mice harboring specific mutations found in CAPS patients were engineered in an attempt to generate preclinical disease-relevant models for genotype-phenotype relationship studies [<xref ref-type="bibr" rid="pbio.3000047.ref025">25</xref>–<xref ref-type="bibr" rid="pbio.3000047.ref028">28</xref>]. These models recapitulate some clinical features though disease manifestations are, in general, more severe in mice than in humans. Nonetheless, these seminal studies revealed that pyroptosis may be responsible for the persistent inflammatory responses in mice with impaired IL-1β and IL-18 signaling [<xref ref-type="bibr" rid="pbio.3000047.ref008">8</xref>, <xref ref-type="bibr" rid="pbio.3000047.ref029">29</xref>]. Here, we used NOMID mice to determine the role that GSDMD and pyroptosis play in this disease model. NOMID mice exhibited systemic inflammation, stunt growth, and damage to multiple organs. These anomalies were absent in NOMID mice lacking GSDMD, which were indistinguishable from wild-type (WT) littermates. These results reveal a nonredundant function of GSDMD in the onset and progression of NOMID in mice.</p>
</sec>
<sec id="sec002" sec-type="conclusions">
<title>Results and discussion</title>
<sec id="sec003">
<title>Maturation of GSDMD and IL-1β, and pyroptosis, occur constitutively in NOMID cells</title>
<p>The NLRP3 inflammasome complex—which comprises NLRP3 itself, the adapter protein, apoptosis-associated speck-like protein containing a CARD (ASC), and caspase-1—processes pro-IL-1β and pro-IL-18 into IL-1β and IL-18, respectively [<xref ref-type="bibr" rid="pbio.3000047.ref001">1</xref>]. This inflammasome also cleaves GSDMD into GSDMD-N and GSDMD-C [<xref ref-type="bibr" rid="pbio.3000047.ref014">14</xref>–<xref ref-type="bibr" rid="pbio.3000047.ref016">16</xref>]. GSDMD-N forms pores at the plasma membranes through which IL-1β and IL-18 are secreted by living cells; excessive pore formation causes pyroptosis, a response that can be assessed in vitro by quantifying the release of lactate dehydrogenase (LDH) [<xref ref-type="bibr" rid="pbio.3000047.ref018">18</xref>, <xref ref-type="bibr" rid="pbio.3000047.ref019">19</xref>]. Consistent with the literature, GSDMD was cleaved upon stimulation of WT mouse bone marrow–derived macrophages (BMMs) with lipopolysaccharide (LPS) and nigericin (<xref ref-type="fig" rid="pbio.3000047.g001">Fig 1A</xref>). Two cleaved GSDMD fragments were detected; whether the larger fragment was further processed to generate the smaller fragment is not known. GSDMD maturation correlated with the release of not only IL-1β (<xref ref-type="fig" rid="pbio.3000047.g001">Fig 1B</xref> and <xref ref-type="supplementary-material" rid="pbio.3000047.s002">S1 Data</xref>) but also LDH (<xref ref-type="fig" rid="pbio.3000047.g001">Fig 1C</xref> and <xref ref-type="supplementary-material" rid="pbio.3000047.s002">S1 Data</xref>), indicating that BMMs undergo NLRP3 inflammasome-dependent pyroptosis under these experimental conditions. To reinforce this conclusion, GSDMD processing, cytokine production, and pyroptosis were determined using cells isolated from mice lacking GSDMD or components of either the NLRP3 canonical inflammasome (e.g., NLRP3 or caspase-1) or noncanonical inflammasome (e.g., caspase-11). Maturation of IL-1β and GSDMD was impaired in BMMs lacking any component of the classical NLRP3 inflammasome but was unaffected in <italic>Casp11</italic> null cells (<xref ref-type="fig" rid="pbio.3000047.g001">Fig 1A–1C</xref>), as expected. These results strengthen the view that GSDMD is a key effector of the NLRP3 inflammasome pathway.</p>
<fig id="pbio.3000047.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pbio.3000047.g001</object-id>
<label>Fig 1</label>
<caption>
<title>GSDMD cleavage correlates with IL-1β secretion and pyroptosis.</title>
<p>BMMs were isolated from WT, <italic>Gsdmd</italic><sup>−/−</sup>, <italic>Nlrp3</italic><sup>−/−</sup>, <italic>Casp1</italic><sup>−/−</sup>, <italic>Casp11</italic><sup>−/−</sup>, NOMID, or NOMID;<italic>Gsdmd</italic><sup>−/−</sup> mice and were expanded in vitro in the presence of M-CSF-containing media. BMMs were primed with LPS for 3 hours and treated with nigericin for 30 minutes. (A, D) Western blot analysis of cell lysates. (B, E) IL-1β levels in conditioned media. (C, F) Percent of LDH release in conditioned media. Data are mean ± SEM from experimental triplicates and are representative of at least three independent experiments. The numerical values underlying Fig 1B, 1C, 1E and 1F can be found in <xref ref-type="supplementary-material" rid="pbio.3000047.s002">S1 Data</xref>. ****<italic>P</italic> &lt; 0.0001. BMM, bone marrow–derived macrophage; Casp, caspase; GSDMD, gasdermin D; IL-1β, interleukin-1β; LDH, lactate dehydrogenase; LPS, lipopolysaccharide; M-CSF, macrophage colony-stimulating factor; NOMID, neonatal-onset multisystem inflammatory disease; WT, wild-type.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000047.g001" xlink:type="simple"/>
</fig>
<p>The identification of more than 100 NLRP3 sequence variants underscores the challenges of genotype–phenotype relationship studies for CAPS [<xref ref-type="bibr" rid="pbio.3000047.ref030">30</xref>]. In efforts to fill this gap, several preclinical CAPS-relevant models were developed [<xref ref-type="bibr" rid="pbio.3000047.ref025">25</xref>–<xref ref-type="bibr" rid="pbio.3000047.ref028">28</xref>]. They included knockin mice, which harbored a D301N NLRP3 mutation, the mouse ortholog of the human D303N mutation found in NOMID patients [<xref ref-type="bibr" rid="pbio.3000047.ref025">25</xref>]. Mating of <italic>Nlrp3</italic><sup><italic>fl(D301N)/+</italic></sup> mice with <italic>lysozyme M-Cre</italic><sup><italic>−/+</italic></sup> (<italic>LysM-Cre</italic><sup><italic>−/+</italic></sup>) mice yielded control and <italic>Nlrp3</italic><sup><italic>fl(D301N)/+</italic></sup>;<italic>LysM-Cre</italic><sup><italic>−/+</italic></sup> mice, in which the autosomal dominant mutation in <italic>Nlrp3</italic> was induced in myeloid cells; these mice are referred to as NOMID mice. We previously reported that the phenotype of NOMID mice with myeloid-restricted activation of NLRP3, which included systemic inflammation and skeletal anomalies, resembled that of mice broadly expressing the mutated protein [<xref ref-type="bibr" rid="pbio.3000047.ref025">25</xref>, <xref ref-type="bibr" rid="pbio.3000047.ref031">31</xref>, <xref ref-type="bibr" rid="pbio.3000047.ref032">32</xref>]. This mouse model provided the opportunity to determine the impact of GSDMD deficiency in the pathogenesis of NOMID. Consistently, GSDMD cleavage in WT BMMs required priming and secondary signals triggered by LPS and nigericin, respectively (<xref ref-type="fig" rid="pbio.3000047.g001">Fig 1D</xref>). By contrast, GSDMD proteolysis in NOMID BMMs was induced by LPS alone though the response was maximal in the presence of the ionophore. Likewise, secretion of IL-1β and LDH by WT cells necessitated the combined actions of LPS and nigericin, whereas these responses were significantly induced by the endotoxin alone in NOMID cells (<xref ref-type="fig" rid="pbio.3000047.g001">Fig 1E and 1F</xref>; and <xref ref-type="supplementary-material" rid="pbio.3000047.s002">S1 Data</xref>). Notably, secretion of IL-1β and LDH was abolished in cells lacking GSDMD. Thus, mature IL-1β is constitutively produced in NOMID cells, but its release requires GSDMD.</p>
</sec>
<sec id="sec004">
<title>Anomalies in NOMID mice are prevented by deletion of <italic>Gsdmd</italic></title>
<p>NOMID mice are runted, and they usually die by 2 to 3 weeks of age [<xref ref-type="bibr" rid="pbio.3000047.ref025">25</xref>, <xref ref-type="bibr" rid="pbio.3000047.ref031">31</xref>], whereas <italic>Gsdmd</italic> null mice are apparently normal [<xref ref-type="bibr" rid="pbio.3000047.ref016">16</xref>]. Consistent with these reports, NOMID pups were indistinguishable from WT and <italic>Gsdmd</italic> null littermates at birth but exhibited growth retardation and significantly lower body weight by 12 days of age (<xref ref-type="fig" rid="pbio.3000047.g002">Fig 2A and 2B</xref>; <xref ref-type="supplementary-material" rid="pbio.3000047.s001">S1A Fig</xref> and <xref ref-type="supplementary-material" rid="pbio.3000047.s002">S1 Data</xref>). Additional macroscopic aberrations in NOMID mice included the presence of skin lesions (<xref ref-type="fig" rid="pbio.3000047.g002">Fig 2A</xref>) and splenomegaly (<xref ref-type="fig" rid="pbio.3000047.g002">Fig 2C and 2D</xref>; <xref ref-type="supplementary-material" rid="pbio.3000047.s002">S1 Data</xref>). Skin and spleen abnormalities and the small body size phenotype of NOMID were all normalized in mutant mice lacking GSDMD (<xref ref-type="fig" rid="pbio.3000047.g002">Fig 2A–2D</xref>). Growth delay, systemic inflammation, perinatal lethality, and spleen and skin abnormalities have been reported for other models of CAPS [<xref ref-type="bibr" rid="pbio.3000047.ref026">26</xref>, <xref ref-type="bibr" rid="pbio.3000047.ref027">27</xref>, <xref ref-type="bibr" rid="pbio.3000047.ref029">29</xref>]. Deletion of <italic>Il-1</italic> receptor completely abolished these outcomes in NOMID mice but not in FCAS and MWS mice [<xref ref-type="bibr" rid="pbio.3000047.ref008">8</xref>, <xref ref-type="bibr" rid="pbio.3000047.ref029">29</xref>], findings that are consistent with the view that, in contrast to humans, FCAS and MWS are unexpectedly more severe than NOMID in mice. The release of not only IL-1β and IL-18 but also other pro-inflammatory factors during pyroptosis may be responsible for the persistent residual inflammatory responses in FCAS and MWS models. Thus, it will be informative to determine the effects of GSDMD deficiency on disease progression in other preclinical models of CAPS.</p>
<fig id="pbio.3000047.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pbio.3000047.g002</object-id>
<label>Fig 2</label>
<caption>
<title>GSDMD deficiency prevents the stunt and splenomegaly phenotype of NOMID mice.</title>
<p>(A) Representative pictures of mice from each genotype. White arrow indicates skin lesions. (B) Body weight of mice. (C) Representative pictures of the spleen of mice from each genotype. (D) Percent of spleen weight. Data are mean ± SEM from WT mice (3 males and 1 female), NOMID mice (3 males and 2 females), NOMID;<italic>Gsdmd</italic><sup><italic>−/−</italic></sup> mice (2 males and 1 female), and <italic>Gsdmd</italic><sup><italic>−/−</italic></sup> mice (3 males and 4 females). The weight of 1 male NOMID;<italic>Gsdmd</italic><sup><italic>−/−</italic></sup> mouse who was left to age is 5 g on day 12, 5.4 g on day 21, and 20.7 g on day 66. The numerical values underlying Fig 2B and 2D can be found in <xref ref-type="supplementary-material" rid="pbio.3000047.s002">S1 Data</xref>. ***<italic>P</italic> &lt; 0.0005; ****<italic>P</italic> &lt; 0.0001. GSDMD, gasdermin D; NOMID, neonatal-onset multisystem inflammatory disease; WT, wild-type.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000047.g002" xlink:type="simple"/>
</fig>
<p>While we were wrapping up this work, a report indicated that lack of GSDMD in mice prevented the onset and progression of Familial Mediterranean Fever, a disease in which aberrant pyrin inflammasome activities caused IL-1β oversecretion and pyroptosis [<xref ref-type="bibr" rid="pbio.3000047.ref033">33</xref>]. Deficiency in GSDMD also protected mice against endotoxic shock, consistent with activation of this protein by intracellular LPS [<xref ref-type="bibr" rid="pbio.3000047.ref014">14</xref>, <xref ref-type="bibr" rid="pbio.3000047.ref016">16</xref>]. A recent paper suggested an interplay between caspase-8 and caspase-11-GSDMD axis in the execution of endotoxic shock [<xref ref-type="bibr" rid="pbio.3000047.ref034">34</xref>]. Collectively, these findings indicate that inactivation of GSDMD arrests pathogenic signals induced by various inflammasomes.</p>
</sec>
<sec id="sec005">
<title>Systemic inflammation and organ damage in NOMID mice are prevented by ablation of <italic>Gsdmd</italic></title>
<p>IL-1β propagates inflammation through various mechanisms, including perturbation of chemokine and cytokine signaling networks, responses that lead to the expansion and recruitment of neutrophils to several organs. This cytokine also promotes anemia owing to its negative effects on erythroid progenitors and erythropoietin signaling as well as alteration of the expression of ferritin and ferroportin [<xref ref-type="bibr" rid="pbio.3000047.ref035">35</xref>–<xref ref-type="bibr" rid="pbio.3000047.ref038">38</xref>]. Accordingly, NOMID mice produced higher levels of IL-1β in bone marrow compared to WT counterparts (<xref ref-type="fig" rid="pbio.3000047.g003">Fig 3A</xref> and <xref ref-type="supplementary-material" rid="pbio.3000047.s002">S1 Data</xref>), a response that correlated with excessive GSDMD processing in vivo in bone marrow, though the cleaved fragment was barely detected in this compartment (<xref ref-type="supplementary-material" rid="pbio.3000047.s001">S1B Fig</xref>). This observation was not unexpected considering that excessive generation of GSDMD-N caused cytolysis; as a result, the cleaved fragment may have been lost during the sampling process. NOMID mice also exhibited peripheral leukocytosis (<xref ref-type="fig" rid="pbio.3000047.g003">Fig 3B</xref> and <xref ref-type="supplementary-material" rid="pbio.3000047.s002">S1 Data</xref>) driven by neutrophilia (<xref ref-type="fig" rid="pbio.3000047.g003">Fig 3C</xref> and <xref ref-type="supplementary-material" rid="pbio.3000047.s002">S1 Data</xref>) and anemia (<xref ref-type="fig" rid="pbio.3000047.g003">Fig 3D</xref>; <xref ref-type="supplementary-material" rid="pbio.3000047.s001">S1C Fig</xref> and <xref ref-type="supplementary-material" rid="pbio.3000047.s002">S1 Data</xref>), as we previously reported [<xref ref-type="bibr" rid="pbio.3000047.ref025">25</xref>, <xref ref-type="bibr" rid="pbio.3000047.ref032">32</xref>]. The identity of myeloid cell subpopulations, which are prone to pyroptosis and propagate inflammation, in this model is unknown, a knowledge gap that future studies should address. In any case, while <italic>Gsdmd</italic> ablation had no effect on the number of blood cells compared to WT mice, it abrogated or attenuated the onset of leukocytosis and anemia in NOMID mice (<xref ref-type="fig" rid="pbio.3000047.g003">Fig 3A–3D</xref>). Accordingly, the bone marrow compartment of NOMID mice contained abnormally high levels of Gr1<sup>+</sup>/CD11b<sup>+</sup> cells and low levels of Ter119<sup>+</sup> cells (<xref ref-type="fig" rid="pbio.3000047.g003">Fig 3E and 3F</xref>; <xref ref-type="supplementary-material" rid="pbio.3000047.s002">S1 Data</xref>), responses that were normalized upon <italic>Gsdmd</italic> deletion.</p>
<fig id="pbio.3000047.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pbio.3000047.g003</object-id>
<label>Fig 3</label>
<caption>
<title>GSDMD deficiency prevents the onset of systemic inflammation in NOMID mice.</title>
<p>(A) IL-1β levels in mouse bone marrow supernatants. (B) WBC counts. (C) Neutrophils. (D) RBCs. (E) Flow cytometry analysis of bone marrow cells stained with antibodies against CD11b, Gr-1, or Ter119. (F) Quantitative data from flow cytometry dot plots shown in panel E. Data are mean ± SEM. Three-week-old mice were used for the studies. WT mice (panel A: 2 males and 1 female; panel B and C: 3 males and 2 females; panel D: 5 males and 4 females; panel F: 2 males and 1 female for CD11b<sup>+</sup>/Gr-1<sup>+</sup>, and 3 males and 1 female for Ter119<sup>+</sup>). NOMID mice (panel A: 2 males and 1 female; panel B and C: 4 males and 3 females; panel D: 4 males and 3 females; panel F: 2 males and 1 female). NOMID;<italic>Gsdmd</italic><sup>−/−</sup> mice (panel A: 2 males and 1 female; panel B–F: 2 males and 1 female); <italic>Gsdmd</italic><sup>−/−</sup> mice: (panel A: 2 males and 1 female; panel B and C: 3 males and 3 females; panel D: 4 males and 4 females; panel F: 3 males and 1 female). The numerical values underlying <xref ref-type="fig" rid="pbio.3000047.g003">Fig 3A, 3B, 3C, 3D and 3F</xref> can be found in <xref ref-type="supplementary-material" rid="pbio.3000047.s002">S1 Data</xref>. *<italic>P</italic> &lt; 0.05; **<italic>P</italic> &lt; 0.005; ***<italic>P</italic> &lt; 0.0005; ****<italic>P</italic> &lt; 0.0001. GSDMD, gasdermin D; IL-1β, interleukin-1β; NOMID, neonatal-onset multisystem inflammatory disease; RBC, red blood cell; WBC, white blood cell; WT, wild-type.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000047.g003" xlink:type="simple"/>
</fig>
<p>Histological analyses showed massive neutrophilic infiltration in the liver, dermal and hypodermal layers of the skin, and the spleen of NOMID mice compared to WT or <italic>Gsdmd</italic><sup>−/−</sup> counterparts (<xref ref-type="fig" rid="pbio.3000047.g004">Fig 4</xref>). Inflammation in the spleen was characterized by disorganized structures of white and red pulps. Because skeletal complications—including low bone mass—are hallmarks of NOMID, we investigated these outcomes in NOMID mice. Histological examinations of skeletal elements showed disorganized columns of chondrocytes with profoundly altered morphology. The epiphysis was hypocellular (<xref ref-type="fig" rid="pbio.3000047.g004">Fig 4</xref>), a phenotype that was previously reported to be caused by massive chondrocyte death [<xref ref-type="bibr" rid="pbio.3000047.ref025">25</xref>, <xref ref-type="bibr" rid="pbio.3000047.ref032">32</xref>] and reminiscent of the human disease [<xref ref-type="bibr" rid="pbio.3000047.ref039">39</xref>]. The number of osteoclasts, cells responsible for bone resorption, was markedly increased in NOMID mice relative to control mice. Remarkably, all organs that were analyzed in NOMID;<italic>Gsdmd</italic><sup>−/−</sup> mice were all spared from inflammation-induced damage (<xref ref-type="fig" rid="pbio.3000047.g004">Fig 4</xref>). Thus, deletion of GSDMD abolishes inflammatory responses and organ demise in NOMID mice.</p>
<fig id="pbio.3000047.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pbio.3000047.g004</object-id>
<label>Fig 4</label>
<caption>
<title>GSDMD deficiency prevents damage to multiple tissues in NOMID mice.</title>
<p>Representative images of liver, skin, and spleen from 3-week-old WT mice (3 males and 1 female), NOMID mice (3 males and 1 female), NOMID;<italic>Gsdmd</italic><sup><italic>−/−</italic></sup> mice (2 males) and <italic>Gsdmd</italic><sup><italic>−/−</italic></sup> mice (3 males and 1 female) stained with HE. Femurs were stained for TRAP activity. Red circle indicates area of hypocellularity in the epiphysis. Osteoclasts are stained in red. Scale bar: 200 μm. GSDMD, gasdermin D; HE, hematoxylin–eosin; NOMID, neonatal-onset multisystem inflammatory disease; TRAP, tartrate-resistant acid phosphatase; WT, wild-type.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000047.g004" xlink:type="simple"/>
</fig>
<p>Blockade of IL-1 activity has been the main strategy for neutralizing pathogenic signals induced by this cytokine in CAPS and other autoinflammatory disorders. However, these drugs have shortcomings, including high cost and the requirement for parenteral administration. Thus, there is still a medical need for the development of safe and affordable drugs for the treatment of autoinflammatory diseases. Breakthrough research demonstrating that GSDMD-mediated pyroptosis releases cytoplasmic contents, including IL-1β and IL-18, offers a novel node for therapeutic intervention. Stemming from its mechanisms of action, blockade of GSDMD and subsequently pyroptosis should, in theory, provide superior efficacy compared with targeted blockade of IL-1β. The compelling evidence indicating that inactivation of GSDMD blocks inflammatory responses induced by the NLRP3 inflammasome lends support to discovery efforts aimed at identifying selective inhibitors of GSDMD actions.</p>
</sec>
</sec>
<sec id="sec006" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="sec007">
<title>Ethics statement</title>
<p>All procedures were approved by the Institutional Animal Care and Use Committee (IACUC) of Washington University School of Medicine in St. Louis, Missouri. All experiments were performed in accordance with the relevant guidelines and regulations described in the IACUC-approved protocol number 20160245.</p>
</sec>
<sec id="sec008">
<title>Mice</title>
<p><italic>Gsdmd</italic><sup>−/−</sup> mice [<xref ref-type="bibr" rid="pbio.3000047.ref016">16</xref>] were kindly provided by Dr. V. M. Dixit (Genentech, South San Francisco, CA). <italic>Nlrp3</italic><sup><italic>−/−</italic></sup>, <italic>Casp1</italic><sup><italic>−/−</italic></sup>, and <italic>Nlrp3</italic><sup><italic>fl(D301N)/+</italic></sup> mice and <italic>lysozyme M (LysM)-Cre</italic> mice have previously been described [<xref ref-type="bibr" rid="pbio.3000047.ref025">25</xref>, <xref ref-type="bibr" rid="pbio.3000047.ref031">31</xref>, <xref ref-type="bibr" rid="pbio.3000047.ref040">40</xref>, <xref ref-type="bibr" rid="pbio.3000047.ref041">41</xref>]. <italic>Casp11</italic><sup><italic>−/−</italic></sup> mice were purchased from The Jackson Laboratory. All mice were on the C57BL6J background, and mouse genotyping was performed by PCR.</p>
</sec>
<sec id="sec009">
<title>Peripheral blood and bone marrow analyses</title>
<p>Complete blood counts were performed by the Washington University School of Medicine DCM Diagnostic Laboratory as previously described [<xref ref-type="bibr" rid="pbio.3000047.ref031">31</xref>]. Bone marrow cells were flushed out as previously described, and photographed [<xref ref-type="bibr" rid="pbio.3000047.ref031">31</xref>].</p>
</sec>
<sec id="sec010">
<title>Cell cultures</title>
<p>BMMs were obtained by culturing mouse bone marrow cells in culture media containing a 1:25 dilution of supernatant from the fibroblastic cell line CMG 14–12 as a source of M-CSF, a mitogenic factor for BMMs, for approximately 5 days in a 10-cm dish following the procedures that we published [<xref ref-type="bibr" rid="pbio.3000047.ref042">42</xref>]. Nonadherent cells were removed by vigorous washes with PBS, and adherent BMMs were detached with trypsin-EDTA and were cultured in culture media containing a 1:50 dilution of CMG at 4 × 10<sup>4</sup>/well in a 96-wells plate (for the analysis of IL-1β and LDH) or 1.2 × 10<sup>6</sup>/well in a 6-wells plate (for Western blot analysis).</p>
</sec>
<sec id="sec011">
<title>Western blot</title>
<p>BMMs were treated with 100 ng/mL LPS for 3 hours, then with 15 μM nigericin for 30 minutes. Extracts from BMMs or bone marrow cells were prepared by lysing cells or cell pellets, respectively, with RIPA buffer (50 mM Tris, 150 mM NaCl, 1 mM EDTA, 0.5% NaDOAc, 0.1% SDS, and 1.0% NP-40) plus phosphatase inhibitors and Complete Protease Inhibitor Cocktail (Roche, Brighton, MA). Protein concentrations were determined by the Bio-Rad method, and equal amounts of proteins were subjected to SDS-PAGE gels (12%). Proteins were transferred onto nitrocellulose membranes and incubated with GSDMD antibody (1:1,000, ab209845, Abcam, Cambridge, MA) or β-actin (1:5,000, sc-47778, Santa Cruz Biotechnology, Dallas, Texas) overnight at 4°C, followed by a 1-hour incubation with secondary goat anti-mouse IgG (1:5,000, A21058, Thermo Fisher Scientific, Grand Island, NY) or goat anti-rabbit IgG (1:5,000, A21109, Thermo Fisher Scientific), respectively. The results were visualized using Li-Cor Odyssey Infrared Imaging System (LI-COR Biosciences, Lincoln, Nebraska).</p>
</sec>
<sec id="sec012">
<title>Flow cytometry</title>
<p>Mouse bone marrow cells were flushed from femur and tibia. For flow cytometry analysis of the leukocytes, red blood cells (RBCs) were depleted with RBC lysis buffer (Roche, Brighton, MA). Cells (0.5–1 × 10<sup>6</sup>) were incubated with Fc block (anti-mouse CD16/32, BioLegend, San Diego, CA) to block nonspecific Fc binding, stained with isotype control or APC-anti-mouse Ter119 (BioLegend, San Diego, CA), FITC-anti-mouse CD11b (eBioscience, Grand Island, NY), and PE-anti-mouse Ly-6G/Ly-6C (Gr1) antibody (BioLegend, San Diego, CA) according to the supplier’s instructions. Flow cytometry was performed using BD LSRFortessa or BD FACSCanto II Flow Cytometer system, followed by analysis with FlowJo software (Tree Star, Ashland, Oregon).</p>
</sec>
<sec id="sec013">
<title>Histology</title>
<p>All tissues were harvested and fixed in 10% formalin. Long bones were decalcified in 14% (w/v) EDTA for 5 days at room temperature. All tissues were embedded in paraffin, sectioned at 5 μm thickness, and mounted on glass slides. Sections were stained with hematoxylin–eosin (HE) or TRAP as previously described [<xref ref-type="bibr" rid="pbio.3000047.ref042">42</xref>].</p>
</sec>
<sec id="sec014">
<title>Cytotoxicity assay and IL-1β ELISA</title>
<p>BMMs were treated with 100 ng/mL LPS for 3 hours, then with 15 μM nigericin for 30 minutes.</p>
<p>Cell death was assessed by the release of LDH using LDH Cytotoxicity Detection Kit (TaKaRa, Mountain View, CA). IL-1β levels in conditioned media were measured by ELISA (eBiosciences, Grand Island, NY). For IL-1β measurements in bone marrow, flushed bone marrow was centrifuged, and the supernatants were collected as described previously [<xref ref-type="bibr" rid="pbio.3000047.ref042">42</xref>]. IL-1β levels were quantified using the eBioscience ELISA kit.</p>
</sec>
<sec id="sec015">
<title>Statistical analysis</title>
<p>Statistical analysis was performed using one-way ANOVA with Tukey's multiple comparisons test or two-way ANOVA with Tukey's multiple comparisons test in GraphPad Prism 7.</p>
</sec>
</sec>
<sec id="sec016">
<title>Supporting information</title>
<supplementary-material id="pbio.3000047.s001" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000047.s001" xlink:type="simple">
<label>S1 Fig</label>
<caption>
<title>GSDMD deficiency prevents the stunt and anemic phenotype of NOMID mice.</title>
<p>(A) Representative pictures of mice from each genotype from a cohort of mice different from the one shown in <xref ref-type="fig" rid="pbio.3000047.g002">Fig 2</xref>. Red arrows indicate skin lesions. Pictures of 12-day-old WT mice (2 males); NOMID mice (1 male and 1 female), NOMID;<italic>Gsdmd</italic><sup><italic>−/−</italic></sup> mice (2 males), and <italic>Gsdmd</italic><sup><italic>−/−</italic></sup> mice (1 male and 1 female). (B) Western blot analysis of bone marrow cell extracts. (C) Pictures of pellets of bone marrow cells isolated from 3-week-old WT, NOMID, NOMID;<italic>Gsdmd</italic><sup>−/−</sup>, or <italic>Gsdmd</italic><sup>−/−</sup> mice.</p>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pbio.3000047.s002" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" position="float" xlink:href="info:doi/10.1371/journal.pbio.3000047.s002" xlink:type="simple">
<label>S1 Data</label>
<caption>
<title>Data for <xref ref-type="fig" rid="pbio.3000047.g001">Fig 1B, 1C, 1E and 1F</xref>, <xref ref-type="fig" rid="pbio.3000047.g002">Fig 2B and 2D</xref>, and <xref ref-type="fig" rid="pbio.3000047.g003">Fig 3A, 3B, 3C, 3D and 3F</xref>.</title>
<p>(XLSX)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>We thank Dr. Vishva M. Dixit for providing <italic>Gsdmd</italic><sup>−/−</sup> mice.</p>
</ack>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item><term>ASC</term>
<def><p>apoptosis-associated speck-like protein containing a CARD</p></def>
</def-item>
<def-item><term>BMM</term>
<def><p>bone marrow–derived macrophage</p></def>
</def-item>
<def-item><term>CAPS</term>
<def><p>cryopyrin-associated periodic syndrome</p></def>
</def-item>
<def-item><term>FCAS</term>
<def><p>familial cold autoinflammatory syndrome</p></def>
</def-item>
<def-item><term>GSDMD</term>
<def><p>gasdermin D</p></def>
</def-item>
<def-item><term>GSDMD-C</term>
<def><p>GSDMD C-terminal domain</p></def>
</def-item>
<def-item><term>GSDMD-N</term>
<def><p>GSDMD N-terminal domain</p></def>
</def-item>
<def-item><term>HE</term>
<def><p>hematoxylin–eosin</p></def>
</def-item>
<def-item><term>IACUC</term>
<def><p>Institutional Animal Care and Use Committee</p></def>
</def-item>
<def-item><term>IL-1β</term>
<def><p>interleukin-1β</p></def>
</def-item>
<def-item><term>LDH</term>
<def><p>lactate dehydrogenase</p></def>
</def-item>
<def-item><term>LPS</term>
<def><p>lipopolysaccharide</p></def>
</def-item>
<def-item><term>M-CSF</term>
<def><p>macrophage colony-stimulating factor</p></def>
</def-item>
<def-item><term>MWS</term>
<def><p>Muckle-Wells syndrome</p></def>
</def-item>
<def-item><term>NOMID</term>
<def><p>neonatal-onset multisystem inflammatory disease</p></def>
</def-item>
<def-item><term>TRAP</term>
<def><p>tartrate-resistant acid phosphatase</p></def>
</def-item>
<def-item><term>WT</term>
<def><p>wild-type</p></def>
</def-item>
</def-list>
</glossary>
<ref-list>
<title>References</title>
<ref id="pbio.3000047.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schroder</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Tschopp</surname> <given-names>J</given-names></name>. <article-title>The inflammasomes</article-title>. <source>Cell</source>. <year>2010</year>;<volume>140</volume>(<issue>6</issue>):<fpage>821</fpage>–<lpage>32</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cell.2010.01.040" xlink:type="simple">10.1016/j.cell.2010.01.040</ext-link></comment> <object-id pub-id-type="pmid">20303873</object-id>.</mixed-citation></ref>
<ref id="pbio.3000047.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Guo</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Callaway</surname> <given-names>JB</given-names></name>, <name name-style="western"><surname>Ting</surname> <given-names>JP</given-names></name>. <article-title>Inflammasomes: mechanism of action, role in disease, and therapeutics</article-title>. <source>Nat Med</source>. <year>2015</year>;<volume>21</volume>(<issue>7</issue>):<fpage>677</fpage>–<lpage>87</lpage>. Epub 2015/06/30. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nm.3893" xlink:type="simple">10.1038/nm.3893</ext-link></comment> <object-id pub-id-type="pmid">26121197</object-id>; PubMed Central PMCID: PMC4519035.</mixed-citation></ref>
<ref id="pbio.3000047.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Broz</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Dixit</surname> <given-names>VM</given-names></name>. <article-title>Inflammasomes: mechanism of assembly, regulation and signalling</article-title>. <source>Nat Rev Immunol</source>. <year>2016</year>;<volume>16</volume>(<issue>7</issue>):<fpage>407</fpage>–<lpage>20</lpage>. Epub 2016/06/14. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nri.2016.58" xlink:type="simple">10.1038/nri.2016.58</ext-link></comment> <object-id pub-id-type="pmid">27291964</object-id>.</mixed-citation></ref>
<ref id="pbio.3000047.ref004"><label>4</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Martinon</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Petrilli</surname> <given-names>V</given-names></name>, <name name-style="western"><surname>Mayor</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Tardivel</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Tschopp</surname> <given-names>J</given-names></name>. <article-title>Gout-associated uric acid crystals activate the NALP3 inflammasome</article-title>. <source>Nature</source>. <year>2006</year>;<volume>440</volume>(<issue>7081</issue>):<fpage>237</fpage>–<lpage>41</lpage>. Epub 2006/01/13. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature04516" xlink:type="simple">10.1038/nature04516</ext-link></comment> <object-id pub-id-type="pmid">16407889</object-id>.</mixed-citation></ref>
<ref id="pbio.3000047.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>de Jesus</surname> <given-names>AA</given-names></name>, <name name-style="western"><surname>Canna</surname> <given-names>SW</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Goldbach-Mansky</surname> <given-names>R</given-names></name>. <article-title>Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling</article-title>. <source>Annu Rev Immunol</source>. <year>2015</year>;<volume>33</volume>:<fpage>823</fpage>–<lpage>74</lpage>. Epub 2015/02/24. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1146/annurev-immunol-032414-112227" xlink:type="simple">10.1146/annurev-immunol-032414-112227</ext-link></comment> <object-id pub-id-type="pmid">25706096</object-id>; PubMed Central PMCID: PMC4563985.</mixed-citation></ref>
<ref id="pbio.3000047.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hoffman</surname> <given-names>HM</given-names></name>, <name name-style="western"><surname>Brydges</surname> <given-names>SD</given-names></name>. <article-title>Genetic and molecular basis of inflammasome-mediated disease</article-title>. <source>The Journal of biological chemistry</source>. <year>2011</year>;<volume>286</volume>(<issue>13</issue>):<fpage>10889</fpage>–<lpage>96</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.R110.135491" xlink:type="simple">10.1074/jbc.R110.135491</ext-link></comment> <object-id pub-id-type="pmid">21296874</object-id>; PubMed Central PMCID: PMCPMC3064144.</mixed-citation></ref>
<ref id="pbio.3000047.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lane</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Loeffler</surname> <given-names>JM</given-names></name>, <name name-style="western"><surname>Rowczenio</surname> <given-names>DM</given-names></name>, <name name-style="western"><surname>Gilbertson</surname> <given-names>JA</given-names></name>, <name name-style="western"><surname>Bybee</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Russell</surname> <given-names>TL</given-names></name>, <etal>et al</etal>. <article-title>AA amyloidosis complicating the hereditary periodic fever syndromes</article-title>. <source>Arthritis Rheum</source>. <year>2013</year>;<volume>65</volume>(<issue>4</issue>):<fpage>1116</fpage>–<lpage>21</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/art.37827" xlink:type="simple">10.1002/art.37827</ext-link></comment> <object-id pub-id-type="pmid">23280696</object-id>.</mixed-citation></ref>
<ref id="pbio.3000047.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McGeough</surname> <given-names>MD</given-names></name>, <name name-style="western"><surname>Wree</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Inzaugarat</surname> <given-names>ME</given-names></name>, <name name-style="western"><surname>Haimovich</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Johnson</surname> <given-names>CD</given-names></name>, <name name-style="western"><surname>Pena</surname> <given-names>CA</given-names></name>, <etal>et al</etal>. <article-title>TNF regulates transcription of NLRP3 inflammasome components and inflammatory molecules in cryopyrinopathies</article-title>. <source>J Clin Invest</source>. <year>2017</year>;<volume>127</volume>(<issue>12</issue>):<fpage>4488</fpage>–<lpage>97</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1172/JCI90699" xlink:type="simple">10.1172/JCI90699</ext-link></comment> <object-id pub-id-type="pmid">29130929</object-id>; PubMed Central PMCID: PMCPMC5707143.</mixed-citation></ref>
<ref id="pbio.3000047.ref009"><label>9</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ter Haar</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Lachmann</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Ozen</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Woo</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Uziel</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Modesto</surname> <given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review</article-title>. <source>Ann Rheum Dis</source>. <year>2013</year>;<volume>72</volume>(<issue>5</issue>):<fpage>678</fpage>–<lpage>85</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/annrheumdis-2011-201268" xlink:type="simple">10.1136/annrheumdis-2011-201268</ext-link></comment> <object-id pub-id-type="pmid">22753383</object-id>.</mixed-citation></ref>
<ref id="pbio.3000047.ref010"><label>10</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Anton</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Calvo</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Fernandez-Martin</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Gamir</surname> <given-names>ML</given-names></name>, <name name-style="western"><surname>Merino</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Jimenez-Trevino</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Efficacy and safety of canakinumab in cryopyrin-associated periodic syndromes: results from a Spanish cohort</article-title>. <source>Clin Exp Rheumatol</source>. <year>2015</year>;<volume>33</volume>(<issue>6</issue> Suppl 94):<fpage>S67</fpage>–<lpage>71</lpage>. Epub 2015/08/06. <object-id pub-id-type="pmid">26243511</object-id>.</mixed-citation></ref>
<ref id="pbio.3000047.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sibley</surname> <given-names>CH</given-names></name>, <name name-style="western"><surname>Plass</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Snow</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Wiggs</surname> <given-names>EA</given-names></name>, <name name-style="western"><surname>Brewer</surname> <given-names>CC</given-names></name>, <name name-style="western"><surname>King</surname> <given-names>KA</given-names></name>, <etal>et al</etal>. <article-title>Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: a cohort study to determine three- and five-year outcomes</article-title>. <source>Arthritis Rheum</source>. <year>2012</year>;<volume>64</volume>(<issue>7</issue>):<fpage>2375</fpage>–<lpage>86</lpage>. Epub 2012/02/02. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/art.34409" xlink:type="simple">10.1002/art.34409</ext-link></comment> <object-id pub-id-type="pmid">22294344</object-id>; PubMed Central PMCID: PMC3474541.</mixed-citation></ref>
<ref id="pbio.3000047.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Neven</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Marvillet</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Terrada</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Ferster</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Boddaert</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Couloignier</surname> <given-names>V</given-names></name>, <etal>et al</etal>. <article-title>Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome</article-title>. <source>Arthritis Rheum</source>. <year>2010</year>;<volume>62</volume>(<issue>1</issue>):<fpage>258</fpage>–<lpage>67</lpage>. Epub 2009/12/30. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/art.25057" xlink:type="simple">10.1002/art.25057</ext-link></comment> <object-id pub-id-type="pmid">20039428</object-id>.</mixed-citation></ref>
<ref id="pbio.3000047.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rigante</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Leone</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Marrocco</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Laino</surname> <given-names>ME</given-names></name>, <name name-style="western"><surname>Stabile</surname> <given-names>A</given-names></name>. <article-title>Long-term response after 6-year treatment with anakinra and onset of focal bone erosion in neonatal-onset multisystem inflammatory disease (NOMID/CINCA)</article-title>. <source>Rheumatol Int</source>. <year>2011</year>;<volume>31</volume>(<issue>12</issue>):<fpage>1661</fpage>–<lpage>4</lpage>. Epub 2011/01/18. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00296-010-1787-5" xlink:type="simple">10.1007/s00296-010-1787-5</ext-link></comment> <object-id pub-id-type="pmid">21240490</object-id>.</mixed-citation></ref>
<ref id="pbio.3000047.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shi</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Zhao</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Shi</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death</article-title>. <source>Nature</source>. <year>2015</year>;<volume>526</volume>(<issue>7575</issue>):<fpage>660</fpage>–<lpage>5</lpage>. Epub 2015/09/17. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature15514" xlink:type="simple">10.1038/nature15514</ext-link></comment> <object-id pub-id-type="pmid">26375003</object-id>.</mixed-citation></ref>
<ref id="pbio.3000047.ref015"><label>15</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ding</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>She</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Sun</surname> <given-names>Q</given-names></name>, <name name-style="western"><surname>Shi</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Pore-forming activity and structural autoinhibition of the gasdermin family</article-title>. <source>Nature</source>. <year>2016</year>;<volume>535</volume>(<issue>7610</issue>):<fpage>111</fpage>–<lpage>6</lpage>. Epub 2016/06/10. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature18590" xlink:type="simple">10.1038/nature18590</ext-link></comment> <object-id pub-id-type="pmid">27281216</object-id>.</mixed-citation></ref>
<ref id="pbio.3000047.ref016"><label>16</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kayagaki</surname> <given-names>N</given-names></name>, <name name-style="western"><surname>Stowe</surname> <given-names>IB</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>BL</given-names></name>, <name name-style="western"><surname>O'Rourke</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Anderson</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Warming</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling</article-title>. <source>Nature</source>. <year>2015</year>;<volume>526</volume>(<issue>7575</issue>):<fpage>666</fpage>–<lpage>71</lpage>. Epub 2015/09/17. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature15541" xlink:type="simple">10.1038/nature15541</ext-link></comment> <object-id pub-id-type="pmid">26375259</object-id>.</mixed-citation></ref>
<ref id="pbio.3000047.ref017"><label>17</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Man</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Karki</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Kanneganti</surname> <given-names>TD</given-names></name>. <article-title>Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases</article-title>. <source>Immunological reviews</source>. <year>2017</year>;<volume>277</volume>(<issue>1</issue>):<fpage>61</fpage>–<lpage>75</lpage>. Epub 2017/05/04. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/imr.12534" xlink:type="simple">10.1111/imr.12534</ext-link></comment> <object-id pub-id-type="pmid">28462526</object-id>; PubMed Central PMCID: PMC5416822.</mixed-citation></ref>
<ref id="pbio.3000047.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Evavold</surname> <given-names>CL</given-names></name>, <name name-style="western"><surname>Ruan</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Tan</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Xia</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Wu</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Kagan</surname> <given-names>JC</given-names></name>. <article-title>The Pore-Forming Protein Gasdermin D Regulates Interleukin-1 Secretion from Living Macrophages</article-title>. <source>Immunity</source>. <year>2018</year>;<volume>48</volume>(<issue>1</issue>):<fpage>35</fpage>–<lpage>44</lpage> e6. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.immuni.2017.11.013" xlink:type="simple">10.1016/j.immuni.2017.11.013</ext-link></comment> <object-id pub-id-type="pmid">29195811</object-id>; PubMed Central PMCID: PMCPMC5773350.</mixed-citation></ref>
<ref id="pbio.3000047.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Heilig</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Dick</surname> <given-names>MS</given-names></name>, <name name-style="western"><surname>Sborgi</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Meunier</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Hiller</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Broz</surname> <given-names>P</given-names></name>. <article-title>The Gasdermin-D pore acts as a conduit for IL-1beta secretion in mice</article-title>. <source>European journal of immunology</source>. <year>2018</year>;<volume>48</volume>(<issue>4</issue>):<fpage>584</fpage>–<lpage>92</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/eji.201747404" xlink:type="simple">10.1002/eji.201747404</ext-link></comment> <object-id pub-id-type="pmid">29274245</object-id>.</mixed-citation></ref>
<ref id="pbio.3000047.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>He</surname> <given-names>WT</given-names></name>, <name name-style="western"><surname>Wan</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Hu</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>X</given-names></name>, <name name-style="western"><surname>Huang</surname> <given-names>Z</given-names></name>, <etal>et al</etal>. <article-title>Gasdermin D is an executor of pyroptosis and required for interleukin-1beta secretion</article-title>. <source>Cell research</source>. <year>2015</year>;<volume>25</volume>(<issue>12</issue>):<fpage>1285</fpage>–<lpage>98</lpage>. Epub 2015/11/28. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/cr.2015.139" xlink:type="simple">10.1038/cr.2015.139</ext-link></comment> <object-id pub-id-type="pmid">26611636</object-id>; PubMed Central PMCID: PMC4670995.</mixed-citation></ref>
<ref id="pbio.3000047.ref021"><label>21</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Russo</surname> <given-names>HM</given-names></name>, <name name-style="western"><surname>Rathkey</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Boyd-Tressler</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Katsnelson</surname> <given-names>MA</given-names></name>, <name name-style="western"><surname>Abbott</surname> <given-names>DW</given-names></name>, <name name-style="western"><surname>Dubyak</surname> <given-names>GR</given-names></name>. <article-title>Active Caspase-1 Induces Plasma Membrane Pores That Precede Pyroptotic Lysis and Are Blocked by Lanthanides</article-title>. <source>Journal of immunology</source>. <year>2016</year>;<volume>197</volume>(<issue>4</issue>):<fpage>1353</fpage>–<lpage>67</lpage>. Epub 2016/07/08. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4049/jimmunol.1600699" xlink:type="simple">10.4049/jimmunol.1600699</ext-link></comment> <object-id pub-id-type="pmid">27385778</object-id>; PubMed Central PMCID: PMC4976007.</mixed-citation></ref>
<ref id="pbio.3000047.ref022"><label>22</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>McKenzie</surname> <given-names>BA</given-names></name>, <name name-style="western"><surname>Mamik</surname> <given-names>MK</given-names></name>, <name name-style="western"><surname>Saito</surname> <given-names>LB</given-names></name>, <name name-style="western"><surname>Boghozian</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Monaco</surname> <given-names>MC</given-names></name>, <name name-style="western"><surname>Major</surname> <given-names>EO</given-names></name>, <etal>et al</etal>. <article-title>Caspase-1 inhibition prevents glial inflammasome activation and pyroptosis in models of multiple sclerosis</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source>. <year>2018</year>;<volume>115</volume>(<issue>26</issue>):<fpage>E6065</fpage>–<lpage>E74</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.1722041115" xlink:type="simple">10.1073/pnas.1722041115</ext-link></comment> <object-id pub-id-type="pmid">29895691</object-id>.</mixed-citation></ref>
<ref id="pbio.3000047.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yang</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Liu</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Yang</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Rathkey</surname> <given-names>JK</given-names></name>, <name name-style="western"><surname>Pinkard</surname> <given-names>OW</given-names></name>, <etal>et al</etal>. <article-title>Mechanism of gasdermin D recognition by inflammatory caspases and their inhibition by a gasdermin D-derived peptide inhibitor</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2018</year>;<volume>115</volume>(<issue>26</issue>):<fpage>6792</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.1800562115" xlink:type="simple">10.1073/pnas.1800562115</ext-link></comment> <object-id pub-id-type="pmid">29891674</object-id>; PubMed Central PMCID: PMCPMC6042100.</mixed-citation></ref>
<ref id="pbio.3000047.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shi</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Gao</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Shao</surname> <given-names>F</given-names></name>. <article-title>Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death</article-title>. <source>Trends in biochemical sciences</source>. <year>2017</year>;<volume>42</volume>(<issue>4</issue>):<fpage>245</fpage>–<lpage>54</lpage>. Epub 2016/12/10. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.tibs.2016.10.004" xlink:type="simple">10.1016/j.tibs.2016.10.004</ext-link></comment> <object-id pub-id-type="pmid">27932073</object-id>.</mixed-citation></ref>
<ref id="pbio.3000047.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bonar</surname> <given-names>SL</given-names></name>, <name name-style="western"><surname>Brydges</surname> <given-names>SD</given-names></name>, <name name-style="western"><surname>Mueller</surname> <given-names>JL</given-names></name>, <name name-style="western"><surname>McGeough</surname> <given-names>MD</given-names></name>, <name name-style="western"><surname>Pena</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Chen</surname> <given-names>D</given-names></name>, <etal>et al</etal>. <article-title>Constitutively activated NLRP3 inflammasome causes inflammation and abnormal skeletal development in mice</article-title>. <source>PloS one</source>. <year>2012</year>;<volume>7</volume>(<issue>4</issue>):<fpage>e35979</fpage>. Epub 2012/05/05. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0035979" xlink:type="simple">10.1371/journal.pone.0035979</ext-link></comment> <object-id pub-id-type="pmid">22558291</object-id>; PubMed Central PMCID: PMC3338787.</mixed-citation></ref>
<ref id="pbio.3000047.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brydges</surname> <given-names>SD</given-names></name>, <name name-style="western"><surname>Mueller</surname> <given-names>JL</given-names></name>, <name name-style="western"><surname>McGeough</surname> <given-names>MD</given-names></name>, <name name-style="western"><surname>Pena</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Misaghi</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Gandhi</surname> <given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity</article-title>. <source>Immunity</source>. <year>2009</year>;<volume>30</volume>(<issue>6</issue>):<fpage>875</fpage>–<lpage>87</lpage>. Epub 2009/06/09. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.immuni.2009.05.005" xlink:type="simple">10.1016/j.immuni.2009.05.005</ext-link></comment> <object-id pub-id-type="pmid">19501000</object-id>; PubMed Central PMCID: PMC2759865.</mixed-citation></ref>
<ref id="pbio.3000047.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Meng</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Zhang</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Fuss</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Kitani</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Strober</surname> <given-names>W</given-names></name>. <article-title>A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses</article-title>. <source>Immunity</source>. <year>2009</year>;<volume>30</volume>(<issue>6</issue>):<fpage>860</fpage>–<lpage>74</lpage>. Epub 2009/06/09. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.immuni.2009.04.012" xlink:type="simple">10.1016/j.immuni.2009.04.012</ext-link></comment> <object-id pub-id-type="pmid">19501001</object-id>; PubMed Central PMCID: PMC2764254.</mixed-citation></ref>
<ref id="pbio.3000047.ref028"><label>28</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Snouwaert</surname> <given-names>JN</given-names></name>, <name name-style="western"><surname>Nguyen</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Repenning</surname> <given-names>PW</given-names></name>, <name name-style="western"><surname>Dye</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Livingston</surname> <given-names>EW</given-names></name>, <name name-style="western"><surname>Kovarova</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>An NLRP3 Mutation Causes Arthropathy and Osteoporosis in Humanized Mice</article-title>. <source>Cell Rep</source>. <year>2016</year>;<volume>17</volume>(<issue>11</issue>):<fpage>3077</fpage>–<lpage>88</lpage>. Epub 2016/12/16. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.celrep.2016.11.052" xlink:type="simple">10.1016/j.celrep.2016.11.052</ext-link></comment> <object-id pub-id-type="pmid">27974218</object-id>.</mixed-citation></ref>
<ref id="pbio.3000047.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brydges</surname> <given-names>SD</given-names></name>, <name name-style="western"><surname>Broderick</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>McGeough</surname> <given-names>MD</given-names></name>, <name name-style="western"><surname>Pena</surname> <given-names>CA</given-names></name>, <name name-style="western"><surname>Mueller</surname> <given-names>JL</given-names></name>, <name name-style="western"><surname>Hoffman</surname> <given-names>HM</given-names></name>. <article-title>Divergence of IL-1, IL-18, and cell death in NLRP3 inflammasomopathies</article-title>. <source>The Journal of clinical investigation</source>. <year>2013</year>;<volume>123</volume>(<issue>11</issue>):<fpage>4695</fpage>–<lpage>705</lpage>. Epub 2013/10/03. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1172/JCI71543" xlink:type="simple">10.1172/JCI71543</ext-link></comment> <object-id pub-id-type="pmid">24084736</object-id>; PubMed Central PMCID: PMC3809806.</mixed-citation></ref>
<ref id="pbio.3000047.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Van Gijn</surname> <given-names>ME</given-names></name>, <name name-style="western"><surname>Ceccherini</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Shinar</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Carbo</surname> <given-names>EC</given-names></name>, <name name-style="western"><surname>Slofstra</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Arostegui</surname> <given-names>JI</given-names></name>, <etal>et al</etal>. <article-title>New workflow for classification of genetic variants' pathogenicity applied to hereditary recurrent fevers by the International Study Group for Systemic Autoinflammatory Diseases (INSAID)</article-title>. <source>J Med Genet</source>. <year>2018</year>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/jmedgenet-2017-105216" xlink:type="simple">10.1136/jmedgenet-2017-105216</ext-link></comment> <object-id pub-id-type="pmid">29599418</object-id>.</mixed-citation></ref>
<ref id="pbio.3000047.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Qu</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Bonar</surname> <given-names>SL</given-names></name>, <name name-style="western"><surname>Hickman-Brecks</surname> <given-names>CL</given-names></name>, <name name-style="western"><surname>Abu-Amer</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>McGeough</surname> <given-names>MD</given-names></name>, <name name-style="western"><surname>Pena</surname> <given-names>CA</given-names></name>, <etal>et al</etal>. <article-title>NLRP3 mediates osteolysis through inflammation-dependent and -independent mechanisms</article-title>. <source>FASEB J</source>. <year>2015</year>;<volume>29</volume>(<issue>4</issue>):<fpage>1269</fpage>–<lpage>79</lpage>. Epub 2014/12/06. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1096/fj.14-264804" xlink:type="simple">10.1096/fj.14-264804</ext-link></comment> <object-id pub-id-type="pmid">25477279</object-id>; PubMed Central PMCID: PMC4396608.</mixed-citation></ref>
<ref id="pbio.3000047.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Xu</surname> <given-names>CX</given-names></name>, <name name-style="western"><surname>Alippe</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Qu</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Xiao</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Schipani</surname> <given-names>E</given-names></name>, <etal>et al</etal>. <article-title>Chronic inflammation triggered by the NLRP3 inflammasome in myeloid cells promotes growth plate dysplasia by mesenchymal cells</article-title>. <source>Scientific reports</source>. <year>2017</year>;<volume>7</volume>(<issue>1</issue>):<fpage>4880</fpage>. Epub 2017/07/09. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41598-017-05033-5" xlink:type="simple">10.1038/s41598-017-05033-5</ext-link></comment> <object-id pub-id-type="pmid">28687790</object-id>; PubMed Central PMCID: PMC5501802.</mixed-citation></ref>
<ref id="pbio.3000047.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kanneganti</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Malireddi</surname> <given-names>RKS</given-names></name>, <name name-style="western"><surname>Saavedra</surname> <given-names>PHV</given-names></name>, <name name-style="western"><surname>Vande Walle</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Van Gorp</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Kambara</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>GSDMD is critical for autoinflammatory pathology in a mouse model of Familial Mediterranean Fever</article-title>. <source>The Journal of experimental medicine</source>. <year>2018</year>;<volume>215</volume>(<issue>6</issue>):<fpage>1519</fpage>–<lpage>29</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1084/jem.20172060" xlink:type="simple">10.1084/jem.20172060</ext-link></comment> <object-id pub-id-type="pmid">29793924</object-id>; PubMed Central PMCID: PMCPMC5987922.</mixed-citation></ref>
<ref id="pbio.3000047.ref034"><label>34</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mandal</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Feng</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Lyons</surname> <given-names>JD</given-names></name>, <name name-style="western"><surname>Berger</surname> <given-names>SB</given-names></name>, <name name-style="western"><surname>Otani</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>DeLaney</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Caspase-8 Collaborates with Caspase-11 to Drive Tissue Damage and Execution of Endotoxic Shock</article-title>. <source>Immunity</source>. <year>2018</year>;<volume>49</volume>(<issue>1</issue>):<fpage>42</fpage>–<lpage>55</lpage> e6. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.immuni.2018.06.011" xlink:type="simple">10.1016/j.immuni.2018.06.011</ext-link></comment> <object-id pub-id-type="pmid">30021146</object-id>; PubMed Central PMCID: PMCPMC6064639.</mixed-citation></ref>
<ref id="pbio.3000047.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kheansaard</surname> <given-names>W</given-names></name>, <name name-style="western"><surname>Panichob</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Fucharoen</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Tanyong</surname> <given-names>DI</given-names></name>. <article-title>Cytokine-induced apoptosis of beta-thalassemia/hemoglobin E erythroid progenitor cells via nitric oxide-mediated process in vitro</article-title>. <source>Acta Haematol</source>. <year>2011</year>;<volume>126</volume>(<issue>4</issue>):<fpage>224</fpage>–<lpage>30</lpage>. Epub 2011/09/22. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1159/000329903" xlink:type="simple">10.1159/000329903</ext-link></comment> <object-id pub-id-type="pmid">21934298</object-id>.</mixed-citation></ref>
<ref id="pbio.3000047.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jelkmann</surname> <given-names>W.</given-names></name> <article-title>Proinflammatory cytokines lowering erythropoietin production</article-title>. <source>J Interferon Cytokine Res</source>. <year>1998</year>;<volume>18</volume>(<issue>8</issue>):<fpage>555</fpage>–<lpage>9</lpage>. Epub 1998/09/03. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1089/jir.1998.18.555" xlink:type="simple">10.1089/jir.1998.18.555</ext-link></comment> <object-id pub-id-type="pmid">9726435</object-id>.</mixed-citation></ref>
<ref id="pbio.3000047.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pinero</surname> <given-names>DJ</given-names></name>, <name name-style="western"><surname>Hu</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Cook</surname> <given-names>BM</given-names></name>, <name name-style="western"><surname>Scaduto</surname> <given-names>RC</given-names> <suffix>Jr.</suffix></name>, <name name-style="western"><surname>Connor</surname> <given-names>JR</given-names></name>. <article-title>Interleukin-1beta increases binding of the iron regulatory protein and the synthesis of ferritin by increasing the labile iron pool</article-title>. <source>Biochim Biophys Acta</source>. <year>2000</year>;<volume>1497</volume>(<issue>3</issue>):<fpage>279</fpage>–<lpage>88</lpage>. Epub 2000/09/21. <object-id pub-id-type="pmid">10996652</object-id>.</mixed-citation></ref>
<ref id="pbio.3000047.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rogers</surname> <given-names>JT</given-names></name>, <name name-style="western"><surname>Bridges</surname> <given-names>KR</given-names></name>, <name name-style="western"><surname>Durmowicz</surname> <given-names>GP</given-names></name>, <name name-style="western"><surname>Glass</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Auron</surname> <given-names>PE</given-names></name>, <name name-style="western"><surname>Munro</surname> <given-names>HN</given-names></name>. <article-title>Translational control during the acute phase response. Ferritin synthesis in response to interleukin-1</article-title>. <source>The Journal of biological chemistry</source>. <year>1990</year>;<volume>265</volume>(<issue>24</issue>):<fpage>14572</fpage>–<lpage>8</lpage>. Epub 1990/08/25. <object-id pub-id-type="pmid">1696948</object-id>.</mixed-citation></ref>
<ref id="pbio.3000047.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hill</surname> <given-names>SC</given-names></name>, <name name-style="western"><surname>Namde</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Dwyer</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Poznanski</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Canna</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Goldbach-Mansky</surname> <given-names>R</given-names></name>. <article-title>Arthropathy of neonatal onset multisystem inflammatory disease (NOMID/CINCA)</article-title>. <source>Pediatr Radiol</source>. <year>2007</year>;<volume>37</volume>(<issue>2</issue>):<fpage>145</fpage>–<lpage>52</lpage>. Epub 2006/12/01. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s00247-006-0358-0" xlink:type="simple">10.1007/s00247-006-0358-0</ext-link></comment> <object-id pub-id-type="pmid">17136361</object-id>.</mixed-citation></ref>
<ref id="pbio.3000047.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Alippe</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Wang</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Ricci</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Xiao</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Qu</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Zou</surname> <given-names>W</given-names></name>, <etal>et al</etal>. <article-title>Bone matrix components activate the NLRP3 inflammasome and promote osteoclast differentiation</article-title>. <source>Scientific reports</source>. <year>2017</year>;<volume>7</volume>(<issue>1</issue>):<fpage>6630</fpage>. Epub 2017/07/28. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41598-017-07014-0" xlink:type="simple">10.1038/s41598-017-07014-0</ext-link></comment> <object-id pub-id-type="pmid">28747793</object-id>; PubMed Central PMCID: PMC5529467.</mixed-citation></ref>
<ref id="pbio.3000047.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Man</surname> <given-names>SM</given-names></name>, <name name-style="western"><surname>Karki</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Briard</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Burton</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Gingras</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Pelletier</surname> <given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Differential roles of caspase-1 and caspase-11 in infection and inflammation</article-title>. <source>Scientific reports</source>. <year>2017</year>;<volume>7</volume>:<fpage>45126</fpage>. Epub 2017/03/28. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/srep45126" xlink:type="simple">10.1038/srep45126</ext-link></comment> <object-id pub-id-type="pmid">28345580</object-id>; PubMed Central PMCID: PMC5366862.</mixed-citation></ref>
<ref id="pbio.3000047.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Hockerman</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Jacobsen</surname> <given-names>EJ</given-names></name>, <name name-style="western"><surname>Alippe</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Selness</surname> <given-names>SR</given-names></name>, <name name-style="western"><surname>Hope</surname> <given-names>HR</given-names></name>, <etal>et al</etal>. <article-title>Selective inhibition of the p38alpha MAPK-MK2 axis inhibits inflammatory cues including inflammasome priming signals</article-title>. <source>J Exp Med</source>. <year>2018</year>;<volume>215</volume>(<issue>5</issue>):<fpage>1315</fpage>–<lpage>25</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1084/jem.20172063" xlink:type="simple">10.1084/jem.20172063</ext-link></comment> <object-id pub-id-type="pmid">29549113</object-id>; PubMed Central PMCID: PMCPMC5940269.</mixed-citation></ref>
</ref-list>
</back>
</article>